The nasolacrimal system has both secretory and drainage components. Drainage of ocular secretions occurs through the puncta of the upper and lower eyelids into the nasolacrimal canaliculi, and subsequently the nasolacrimal sac, a dilation smaller than in most other species. The sac drains to the nasolacrimal duct in the lacrimal canal of the lacrimal and maxillary bones, then opens into the ventrolateral nasal cavity. Dacryocystitis is inflammation of the lacrimal sac and/or NLD. It is seen frequently in horses.
There are no breed predilections for or known genetic influence on development of dacryocystitis.
One must differentiate dacryocystitis from other causes of mucopurulent ocular discharge, including bacterial or parasitic conjunctivitis, neoplasia of eyelid or conjunctiva, secondary infection following ocular or eyelid injury, ocular foreign body.
Patients that require surgical intervention to reestablish patency of the duct would be hospitalized on a short-term basis. Those in which patency is reestablished with simple irrigation or cannulation can be treated on an outpatient basis.
No change in diet is necessary. Hay should be fed at ground level rather than from elevated hayracks or bags if ocular disease is present.
Clients should be informed of the potential for recurrence in cases of acquired obstruction or when a cause is unidentified.
The patient should be rechecked soon after the initial procedure to establish patency (710 days), with the specific time frame determined by severity. Subsequent rechecks are dictated by severity of disease and response to treatment.
Fly control in barns and pastures, fly hoods, frequent periocular administration of insect repellent, and regular deworming with avermectins, decreasing environmental dust, debris, and other material that may accumulate in the NLD, and decreasing the amount or exposure to allergens may prevent the development of or decrease the incidence or severity of NLD obstructions and dacryocystitis.
Potential complications vary with the inciting cause. They include recurrence of the dacryocystitis and failure to maintain patency of the duct.
Systemic absorption of topically applied medication is possible. Benefits of treatment should be considered against any risks posed to the fetus.
Brooks DE. Ophthalmology for the Equine Practitioner, 2e. Jackson, WY: Teton NewMedia, 2008.
Gilger BC. Equine ophthalmology. In: Gelatt KN, Gilger BC, Kern TJ, eds. Veterinary Ophthalmology, 5e. Ames, IA: Wiley Blackwell, 2013:15601609.
Gilger BC. Equine Ophthalmology, 3e. Philadelphia, PA: WB Saunders, 2017.